Prime Medicine Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
15 Feb 24 | BuyUS$20,000,000 | Arch Venture Partners, L.P. | Company | 3,200,000 | US$6.25 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 21,011 | 0.0182% |
Public Companies | 1,608,337 | 1.4% |
General Public | 14,908,004 | 12.9% |
Individual Insiders | 25,676,021 | 22.3% |
Institutions | 36,454,673 | 31.6% |
VC/PE Firms | 36,624,771 | 31.8% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 30.5%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
20,156,945 | US$106.2m | 0% | no data | |||
15,456,594 | US$81.5m | 26.1% | 5.55% | |||
15,062,498 | US$79.4m | 27% | 6.34% | |||
6,105,679 | US$32.2m | 15.1% | no data | |||
5,993,354 | US$31.6m | 91% | 0.22% | |||
4,361,078 | US$23.0m | 0% | no data | |||
4,054,911 | US$21.4m | 2.61% | no data | |||
3,921,507 | US$20.7m | 0% | 7.8% | |||
3,778,618 | US$19.9m | 13.3% | no data | |||
3,364,663 | US$17.7m | -4.39% | 0.01% | |||
2,221,159 | US$11.7m | 2.2% | no data | |||
1,792,210 | US$9.4m | 0% | 8.07% | |||
1,608,337 | US$8.5m | 0% | no data | |||
1,324,350 | US$7.0m | 0% | 0.26% | |||
1,028,466 | US$5.4m | 0% | 0.06% | |||
965,001 | US$5.1m | 0% | no data | |||
887,503 | US$4.7m | 4.83% | no data | |||
885,314 | US$4.7m | 0% | 0.08% | |||
759,758 | US$4.0m | -54.9% | no data | |||
513,001 | US$2.7m | 16.9% | 0.21% | |||
470,304 | US$2.5m | 0% | 0.44% | |||
397,246 | US$2.1m | 54.5% | no data | |||
367,175 | US$1.9m | 0% | 0.15% | |||
361,136 | US$1.9m | 0% | 0.05% | |||
344,927 | US$1.8m | 3.59% | no data |